Bookmark and Share
BioAssay: AID 2097

Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity

The glycogen synthase kinase-3 beta (GSK-3b) is a known master regulator for several cellular pathways and plays a critical role in metabolism, transcription, development, cell survival, and neuronal functions. The overall objective is to identify one or multiple series of inhibitors of GSK-3beta with micromolar potency. Such compounds will become probe(s) with demonstrated kinase-selectivity more ..
_
   
 Tested Compounds
 Tested Compounds
All(302439)
 
 
Active(116)
 
 
Inactive(302323)
 
 
 Tested Substances
 Tested Substances
All(302503)
 
 
Active(116)
 
 
Inactive(302387)
 
 
AID: 2097
Data Source: Broad Institute (2046-01_INHIBITORS_SINGLE-POINT_MLPCN-HTS)
BioAssay Type: Primary, Primary Screening, Single Concentration Activity Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
BioAssay Version:
Deposit Date: 2009-11-03
Modify Date: 2010-05-26

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: 116
Related Experiments
Show more
AIDNameTypeComment
2119Summary of Probe Development Efforts to Identify Inhibitors of Glycogen Synthase Kinase-3 beta (GSK-3b)Summarydepositor-specified cross reference
434947Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo ReagentsConfirmatorydepositor-specified cross reference
434954Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta ActivityConfirmatorydepositor-specified cross reference
435010Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing ActivityConfirmatorydepositor-specified cross reference
463199Luminescence Whole-Organism Secondary Assay to Identify Compounds Inducing Growth of Temperature Sensitive Mutant Burl-1Confirmatorydepositor-specified cross reference
623978Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatorysame project related to Summary assay
623979Inhibition of Human CDK5 Activity Measured in Biochemical System Using Microfluidics - 2046-12_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatorysame project related to Summary assay
623989Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatorysame project related to Summary assay
623998GSK3beta Measured in Biochemical System Using Plate Reader - 2046-01_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
623999CDK5 Measured in Biochemical System Using Plate Reader - 2046-05_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
624027GSK3beta Assay at Varied ATP concentrations Measured in Biochemical System Using Plate Reader - 2046-04_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
624057Human p-Tau and Total Tau ELISA Measured in Cell-Based System Using Plate Reader - 2133-07_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
624076Kinome profiling single dose point Measured in Biochemical System Using Plate Reader - 2133-09_Inhibitor_SinglePoint_DryPowder_ActivityOthersame project related to Summary assay
624086TCF/LEF Reporter Assay Measured in Cell-Based System Using Plate Reader - 2133-01_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
624088PathHunter bCatenin (U2-OS) Measured in Cell-Based System Using Plate Reader - 2133-06_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
624091Dose responses of selected compounds against GSK3b Measured in Biochemical System Using Plate Reader - 2133-10_Inhibitor_Dose_DryPowder_ActivityOthersame project related to Summary assay
624108GSK3beta Surface Plasmon Resonance (SPR) Assay Measured in Biochemical System Using Microfluidics - 2133-08_Inhibitor_Dose_DryPowder_ActivityOthersame project related to Summary assay
Description:
Keywords: GSK3beta, kinase, inhibition, HTS

Assay Overview:
The glycogen synthase kinase-3 beta (GSK-3b) is a known master regulator for several cellular pathways and plays a critical role in metabolism, transcription, development, cell survival, and neuronal functions. The overall objective is to identify one or multiple series of inhibitors of GSK-3beta with micromolar potency. Such compounds will become probe(s) with demonstrated kinase-selectivity (≥10-fold IC50) and activation of Wnt signaling (EC50 < 10uM) and desired effect on neuronal morphology. Structural series that demonstrates non-ATP competitive mechanism of action will be strongly preferred. For primary screen, activity of 1.6 ng of GSK3beta (as a GST fusion from BPS Bioscience) was incubated with 10 uM of compounds in the presence of 25 uM of ATP (specific reaction conditions see Protocol) for 60 minutes at ambient temperature in 1536 plates (Aurora 29847). The kinase activity was measured with ADP-Glo (Promega V9103) and signals were read with Viewlux (PerkinElmer). Positive control (GW8510 at 20 uM) was included in each plate and used to scale the data in conjunction with in-plate DMSO controls (details see Data Analysis or Comments section).

Expected Outcome:
Inhibitors for GSK3beta activity will show as loss of luminescence signal.
Protocol
1) Dispense 1 uL/well of CABPE, 0.5 uL of ATP, and 1 uL of positive control GW8510 or AB in respective wells according to plate design to 1536-well assay ready plates (Aurora 29847) that contain 2.5 nL/well of 10 mM compound using BioRAPTR (Beckman) to start the reaction. Incubate at room temperature for 60 minutes.
2) Add 2.5 uL/well of ADP-glo (Promega, V9103) with BioRAPTR, incubate at room temperature for 40 minutes
3) Add 5 uL/well of ADP-glo (Promega, V9103) with Combi nL (Thermo), incubate at room temperature for 30 minutes
4) Read on Viewlux (PerkinElmer) for luminescence
Solutions:
AB:
25 mM Tris7.5
10 mM MgCl2
GW8510 (in AB, Sigma G7791)
50 uM GW8510
CABPE (in AB):
12.5 mM DTT (Sigma 43816)
0.25 mg/ml BSA (Sigma A4503)
0.5 U/ml Heparin (Baxter NDC 0641-2440-41)
8 uM Peptide (American Peptide)
23 nM GSK3beta (BPS Biosciences)
ATP (in AB, Promega V9103 component):
125 uM ATP
Comment
HTS Data Analysis
Each compound was tested in singlicate in 1536-well plates; a small percentage of compounds were duplicated.
128 neutral control wells (DMSO) and 128 positive control wells were included on every plate.
Active inhibitor compounds result in decreased signal.
Analysis used to determine PubChem Activity Score and Outcome
The raw luminescent signal of the DMSO control wells was normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral controls (NC) is set to a normalized activity value of 0.
The median raw signal of the intraplate positive (active) controls (AC) is set to a normalized activity value of -100.
This normalization was then applied to all compound treated wells, giving an activity score as percent change in luminescence signal relative to the intraplate controls.
A plate correction matrix was applied using the 'Run-wise Multiplicative Correction' in Genedata Assay Analyzer (v7.0.3)
The final PUBCHEM_ACTIVITY_SCORE was calculated by multiplying the mean of all valid replicate values (which can be described in units of negative percent activity) by -1, resulting in a score between 0 and 100 (in units of 'percent inhibition'). Most wells were not tested in replicate, so the mean of the well activity value was the same as the well value itself.
The PUBCHEM_ACTIVITY_OUTCOME class was assigned as described below, based on an activity threshold of -50%:
Activity_Outcome = 1 (inactive)
0% of replicates fall outside threshold.
Activity_Outcome = 2 (active)
>50% of replicates fall outside threshold.
Activity_Outcome = 3 (inconclusive)
>0% and <= 50% of replicates fall outside threshold. (None for singlicates.)
Result Definitions
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1REPRODUCIBILITY_COSINE_TRANSFORMA measure of how well the activity reproduced across the two
samples. Computed as the absolute value of the cosine between the "replicate vector"
(ScoreA, ScoreB ---as well as ScoreC and/or ScoreD where applicable) and the vector (1, 1) representing perfect reproducibility.
NULL will appear in this column if a sample was not run in duplicate or if the data produced by one of the replicates was Invalid
Float
2BROAD_SCREENING_RUNIDSThis is a comma separated list of unique IDs given to each screening run at the Broad Institute.String
3REPLICATE_A_ACTIVITY_SCOREThe calculated activity score of the indicated replicate.Float%
4REPLICATE_B_ACTIVITY_SCOREThe calculated activity score of the indicated replicate.Float%
5DATE_REPORTEDDate data reported internallyString
Additional Information
Grant Number: 1 R03 MH087442-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
Classification
PageFrom: